Mankind Pharma Limited (MANKIND.NS)
INR 2350.5
(1.58%)
INR 2350.5
(1.58%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 103.34 Billion INR | 18.21% |
| 2022 | 87.42 Billion INR | 12.35% |
| 2021 | 77.81 Billion INR | 25.22% |
| 2020 | 62.14 Billion INR | 5.95% |
| 2019 | 58.65 Billion INR | 17.78% |
| 2018 | 49.79 Billion INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 28.93 Billion INR | 18.53% |
| 2023 Q1 | 25.78 Billion INR | 25.62% |
| 2023 Q2 | 27.08 Billion INR | 5.02% |
| 2023 Q3 | 26.06 Billion INR | -3.73% |
| 2023 Q4 | 24.41 Billion INR | -6.36% |
| 2023 FY | 103.34 Billion INR | 18.21% |
| 2022 Q1 | 21.79 Billion INR | 26.32% |
| 2022 FY | 87.42 Billion INR | 12.35% |
| 2022 Q4 | 20.52 Billion INR | -1.83% |
| 2022 Q2 | 24.25 Billion INR | 11.28% |
| 2022 Q3 | 20.9 Billion INR | -13.81% |
| 2021 FY | 77.81 Billion INR | 25.22% |
| 2021 Q4 | 17.25 Billion INR | 0.0% |
| 2020 FY | 62.14 Billion INR | 5.95% |
| 2019 FY | 58.65 Billion INR | 17.78% |
| 2018 FY | 49.79 Billion INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 61.12 Billion INR | -69.087% |
| Hester Biosciences Limited | 3.04 Billion INR | -3293.502% |
| Aarti Drugs Limited | 25.28 Billion INR | -308.719% |
| Aarti Pharmalabs Limited | 18.15 Billion INR | -469.251% |
| Albert David Limited | 3.62 Billion INR | -2751.274% |
| Alembic Limited | 1.57 Billion INR | -6462.374% |
| Alkem Laboratories Limited | 126.67 Billion INR | 18.416% |
| Bafna Pharmaceuticals Limited | 1.52 Billion INR | -6678.426% |
| Bajaj HealthCare Limited | 4.73 Billion INR | -2083.013% |
| Biofil Chemicals and Pharmaceuticals Limited | 400.35 Million INR | -25714.156% |
| Brooks Laboratories Limited | 794.86 Million INR | -12901.99% |
| Eris Lifesciences Limited | 20.09 Billion INR | -414.387% |
| FDC Limited | 19.42 Billion INR | -431.913% |
| Glenmark Life Sciences Limited | 22.83 Billion INR | -352.642% |
| Gufic Biosciences Limited | 8.06 Billion INR | -1181.172% |
| Hikal Limited | 17.84 Billion INR | -479.109% |
| Ind-Swift Limited | 5.02 Billion INR | -1956.802% |
| Innova Captab Limited | 10.81 Billion INR | -855.769% |
| IOL Chemicals and Pharmaceuticals Limited | 21.32 Billion INR | -384.566% |
| Jagsonpal Pharmaceuticals Limited | 2.08 Billion INR | -4851.929% |
| Jubilant Pharmova Limited | 67.02 Billion INR | -54.184% |
| Lincoln Pharmaceuticals Limited | 5.8 Billion INR | -1680.171% |
| Lupin Limited | 196.56 Billion INR | 47.423% |
| Mangalam Drugs & Organics Limited | 3.67 Billion INR | -2713.304% |
| Medico Remedies Limited | 1.44 Billion INR | -7031.331% |
| Morepen Laboratories Limited | 17.01 Billion INR | -507.25% |
| Nectar Lifesciences Limited | 16.84 Billion INR | -513.496% |
| Orchid Pharma Limited | 8.19 Billion INR | -1161.31% |
| Procter & Gamble Health Limited | 11.51 Billion INR | -797.692% |
| RPG Life Sciences Limited | 5.82 Billion INR | -1675.582% |
| Kilitch Drugs (India) Limited | 1.54 Billion INR | -6594.699% |
| Sigachi Industries Limited | 3.98 Billion INR | -2490.454% |
| Solara Active Pharma Sciences Limited | 12.38 Billion INR | -734.533% |
| Suven Pharmaceuticals Limited | 10.51 Billion INR | -882.997% |
| Themis Medicare Limited | 3.81 Billion INR | -2607.134% |
| Unichem Laboratories Limited | 16.57 Billion INR | -523.547% |
| Vaishali Pharma Limited | 862.79 Million INR | -11878.223% |
| Wanbury Limited | 5.75 Billion INR | -1695.323% |
| Windlas Biotech Limited | 6.3 Billion INR | -1537.955% |
| ZIM Laboratories Limited | 3.67 Billion INR | -2712.053% |
| Ind-Swift Laboratories Limited | 12.8 Billion INR | -706.837% |
| Ipca Laboratories Limited | 77.05 Billion INR | -34.115% |
| Sun Pharmaceutical Industries Limited | 484.96 Billion INR | 78.69% |
| Venus Remedies Limited | 5.91 Billion INR | -1647.364% |
| Sakar Healthcare Limited | 1.54 Billion INR | -6603.61% |
| Aurobindo Pharma Limited | 290.01 Billion INR | 64.365% |
| Divi's Laboratories Limited | 78.45 Billion INR | -31.737% |
| AstraZeneca Pharma India Limited | 12.95 Billion INR | -697.726% |
| Sequent Scientific Limited | 13.69 Billion INR | -654.511% |
| Laurus Labs Limited | 50.01 Billion INR | -106.621% |
| Neuland Laboratories Limited | 15.58 Billion INR | -563.089% |
| J. B. Chemicals & Pharmaceuticals Limited | 34.47 Billion INR | -199.761% |
| Glenmark Pharmaceuticals Limited | 118.13 Billion INR | 12.514% |
| Zydus Lifesciences Limited | 190.21 Billion INR | 45.668% |
| Amrutanjan Health Care Limited | 4.21 Billion INR | -2353.473% |
| Wockhardt Limited | 27.89 Billion INR | -270.555% |
| Bal Pharma Limited | 3.39 Billion INR | -2946.633% |
| Dr. Reddy's Laboratories Limited | 279.16 Billion INR | 62.98% |
| Bliss GVS Pharma Limited | 7.7 Billion INR | -1241.752% |
| Par Drugs and Chemicals Limited | 956.4 Million INR | -10705.867% |
| Caplin Point Laboratories Limited | 16.76 Billion INR | -516.346% |
| Shilpa Medicare Limited | 11.53 Billion INR | -796.255% |
| Valiant Laboratories Limited | 1.82 Billion INR | -5576.663% |
| Ajanta Pharma Limited | 42.08 Billion INR | -145.557% |
| Aarey Drugs & Pharmaceuticals Limited | 3.95 Billion INR | -2512.312% |
| Granules India Limited | 45.06 Billion INR | -129.337% |
| Medicamen Biotech Limited | 1.79 Billion INR | -5663.758% |
| Syncom Formulations (India) Limited | 2.59 Billion INR | -3886.505% |
| Piramal Enterprises Limited | 60.33 Billion INR | -71.283% |
| Torrent Pharmaceuticals Limited | 106.05 Billion INR | 2.552% |
| NATCO Pharma Limited | 40.02 Billion INR | -158.24% |
| Suven Life Sciences Limited | 116.92 Million INR | -88285.042% |
| Krebs Biochemicals & Industries Limited | 504.21 Million INR | -20396.762% |
| Strides Pharma Science Limited | 40.51 Billion INR | -155.109% |
| Indoco Remedies Limited | 18.17 Billion INR | -468.692% |
| Alpa Laboratories Limited | 1.08 Billion INR | -9404.202% |
| Lasa Supergenerics Limited | 1.04 Billion INR | -9805.377% |
| Sun Pharma Advanced Research Company Limited | 755.45 Million INR | -13580.235% |